Vaxart director buys 10,000 shares in open market
Vaxart, Inc. director Watson W. Mark reported an open-market purchase of 10,000 shares of Common Stock on May 22, 2026 at $0.653 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Vaxart, Inc. director Watson W. Mark reported an open-market purchase of 10,000 shares of Common Stock on May 22, 2026 at $0.653 per share. Following this transaction, he directly holds 134,125 shares of Vaxart common stock.
Insider Trade Summary
Net Buyer: 10,000 shares
Net Buy
1 txn
Insider
Watson W. Mark
Role
Director
Bought
10,000 shs ($7K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 10,000 | $0.653 | $7K |
Holdings After Transaction:
Common Stock — 134,125 shares (Direct)
Key Figures
Shares purchased: 10,000 shares
Purchase price: $0.653 per share
Total direct holdings: 134,125 shares
+1 more
4 metrics
Shares purchased
10,000 shares
Open-market purchase of Vaxart Common Stock
Purchase price
$0.653 per share
Price paid on May 22, 2026 transaction
Total direct holdings
134,125 shares
Shares owned directly after the transaction
Net buy shares
10,000 shares
Net-buy direction from transaction summary
Key Terms
open-market purchase, Common Stock, Form 4, net-buy
4 terms
open-market purchase financial
"transaction_action: "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
net-buy financial
"netBuySellDirection: "net-buy""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Vaxart (VXRT) report for Watson W. Mark?
Vaxart reported that director Watson W. Mark made an open-market purchase of 10,000 shares of Common Stock. The transaction was disclosed on Form 4 and reflects a direct acquisition of Vaxart equity rather than a grant, gift, or tax-related withholding.
What is Watson W. Mark’s total Vaxart (VXRT) holding after this transaction?
After the reported purchase, Watson W. Mark directly owns 134,125 shares of Vaxart Common Stock. This figure, disclosed in the Form 4, reflects his total direct holdings immediately following the 10,000-share open-market acquisition.
Was the Vaxart (VXRT) insider trade a buy or a sell?
The transaction was a buy, specifically an open-market purchase coded as “P” on Form 4. It involved acquiring 10,000 Vaxart Common Stock shares, increasing the director’s direct ownership to 134,125 shares after the trade was completed.
Does the Vaxart (VXRT) Form 4 show any derivative transactions?
The Form 4 data show no derivative transactions for this event. All reported activity relates to non-derivative Common Stock, with a single open-market purchase and no associated options exercises, conversions, gifts, or tax-withholding dispositions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates